K-numberK243735
Device nameZiehm Vision FD
ApplicantZiehm Imaging GmbH
Product codeOWB
Device classClass II
Decision dateMar 13, 2025
DecisionSubstantially Equivalent
Regulation892.1650
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Ziehm Vision FD is a mobile fluoroscopy system that provides real-time 2D medical imaging during diagnostic, interventional, and surgical procedures. It visualizes complex anatomical structures in vascular, cardiac, endoscopic, orthopedic, neurologic, and emergency room procedures, but does not support direct radiographic film or mammography, and is not intended for use near MRI systems.

Technological characteristics

The key modification is a software update to version 7.10.0 incorporating the 2k imaging chain 'QuantumStream' with a new 'Image Insights' overlay. In addition to the existing 8-inch IGZO flat panel detector, the modified device offers an additional IGZO panel detector; both detectors use identical Indium-Gallium-Zinc-Oxide manufacturing technology, detector size, and image quality.

Test standards cited

21 CFR 1020.30-32 (Federal Performance Standards for X-Ray Fluoroscopic equipment); ANSI AAMI ES60601-1:2021; IEC 60601-1-2:2020; IEC 60601-1-3:2021; IEC 60601-2-43:2022; IEC 60601-2-54:2022. Testing also referenced FDA guidance on solid-state x-ray imaging devices (September 2016), pediatric x-ray imaging (November 2017), device software functions (June 2023), and cybersecurity (September 2023).

Substantial equivalence argument

The predicate and modified device share substantially equivalent indications for use, design controls, functionality, and technology. Image quality testing with anthropomorphic and motion-induced phantoms showed the modified device's images are equal or superior in detail, detectability, and sharpness. Pediatric dose testing confirmed sufficient image quality. Software and cybersecurity testing demonstrated acceptable vulnerability profiles and no stability or security issues. All verification and validation activities confirmed device requirements are met and functionality performs as designed with no new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →